Open AccessPrevention of Bone Loss after Allogeneic Stem Cell Transplantation by Calcium, Vitamin D, and Sex Hormone Replacement with or without Pamidronate
Author(s) -
Kristiina Kananen,
Liisa Volin,
Kalevi Laitinen,
Henrik Alfthan,
Tapani Ruutu,
Matti Välimäki
Publication year - 2005
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2004-2161
Subject(s) - vitamin d and neurology , hormone replacement therapy (female to male) , transplantation , medicine , calcium , stem cell , hormone , hormone replacement , endocrinology , testosterone (patch) , biology , genetics
In controlled studies, bisphosphonates have been used to prevent bone loss after solid organ transplantations but not in conjunction with stem cell transplantation (SCT).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom